Brief: Aptevo Therapeutics Announces 1-For 44 Reverse Stock Split
March 4 (Reuters) - Aptevo Therapeutics Inc APVO.O :
* APTEVO THERAPEUTICS ANNOUNCES 1-FOR 44 REVERSE STOCK SPLIT
AS
PART OF NASDAQ COMPLIANCE PLAN
* APTEVO THERAPEUTICS INC - REVERSE STOCK SPLIT IS EXPECTED
TO
BECOME EFFECTIVE ON MARCH 5, 2024 AT 5:01 P.M. EASTERN TIME
* APTEVO THERAPEUTICS INC - SHARES EXPECTED TO BEGIN TRADING
ON
NASDAQ CAPITAL MARKET, ON A SPLIT-ADJUSTED, AT MARKET OPEN ON
MARCH 6
Further company coverage: APVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary